Last €74.70 EUR
Change Today +1.84 / 2.53%
Volume 0.0
CLH On Other Exchanges
New York
As of 1:43 PM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

cardinal health inc (CLH) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/23/15 - €74.80
52 Week Low
05/8/14 - €45.55
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CARDINAL HEALTH INC (CLH)

cardinal health inc (CLH) Related Businessweek News

View More BusinessWeek News

cardinal health inc (CLH) Details

Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers. This segment offers distribution, inventory management, data reporting, new product launch support, and contract pricing and chargeback administration services to pharmaceutical manufacturers; operates nuclear pharmacies and cyclotron facilities that manufacture, prepare, and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices; franchises retail pharmacies under the Medicine Shoppe and Medicap brands; provides pharmacy services to hospitals and other healthcare facilities; and offers logistics, marketing, and other services. This segment also provides various consulting and other services to pharmaceutical manufacturers, third-party payors, and healthcare providers. The Medical segment distributes a range of medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, physician offices, and other healthcare providers; and offers supply chain services, including spend, distribution, and inventory management services to healthcare providers. This segment also develops, manufactures, and sources a line of private brand medical and surgical products comprising surgical drapes, gowns, and apparel; exam and surgical gloves; and fluid suction and collection systems, as well as sterile and non-sterile procedure kits directly or through third-party distributors. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

34,000 Employees
Last Reported Date: 08/13/14
Founded in 1979

cardinal health inc (CLH) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.3M
Chief Financial Officer
Total Annual Compensation: $647.7K
Chief Executive Officer of Medical Segment
Total Annual Compensation: $647.7K
Chief Legal and Compliance Officer
Total Annual Compensation: $508.5K
Executive Officer
Total Annual Compensation: $756.9K
Compensation as of Fiscal Year 2014.

cardinal health inc (CLH) Key Developments

Cardinal Health, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 11:00 AM

Cardinal Health, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 11:00 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: George S. Barrett, Chairman, Chief Executive Officer and Chairman of Executive Committee.

Bayer Appoints Cardinal Health as U.S. Based Contract Manufacturer for Xofigo® Injection

Bayer HealthCare and Cardinal Health announced the signing of a 15-year agreement for the contract manufacturing of Xofigo® (radium Ra 223 dichloride).  As part of the agreement, Cardinal Health will build a 64,000 square foot facility in Indianapolis, which will be dedicated exclusively to the manufacturing of Xofigo.  Product manufactured at this facility will primarily be distributed in the United States and Canada. The manufacturing facility will be built near and leverage the capabilities and talent of Cardinal Health's existing Indianapolis radiopharmacy, which is one of the two U.S. locations authorized by Bayer HealthCare to distribute Xofigo. Cardinal Health is the sole distributor of Xofigo in the U.S. Xofigo is an alpha-particle-emitting radioactive therapeutic agent for the treatment of patients with castration-resistant prostate cancer (CRPC), symptomatic bone metastases and no known visceral metastatic disease. Bayer HealthCare is developing and marketing Xofigo worldwide. The current manufacturing site in Norway will continue to be responsible for global supply of the product.  Bayer had started the preparations for a second manufacturing site soon after the first marketing authorization for Xofigo was obtained in May 2013. The new Cardinal Health manufacturing facility, slated for completion in 2017, will be built and equipped for the unique manufacturing needs of Xofigo.  It will be supported by approximately 85 employees, including specialized manufacturing roles, chemists, engineers and other professional positions.

Cardinal Health Launches New Analytics Tool to Help Hospitals Improve Antibiotic Stewardship Efforts

Cardinal Health introduced a powerful new tool that gives pharmacists the ability to rapidly analyze antibiotic use trends and identify significant opportunities to improve antibiotic stewardship efforts. Cardinal Health's new Antibiotic Analytics dashboard helps pharmacists address these trends. It is part of Cardinal Health's Drug Cost Opportunity Analytics software package, a web-based technology that provides data and insights to help hospital pharmacy leaders manage drug spend. The new dashboard tracks and benchmarks antibiotic selection and use over time, by Defined Daily Dose or Days of Therapy. It then evaluates susceptibility and resistance patterns, and determines the best pharmaceutical agent for each hospital's specific patient population. The new Antibiotic Analytics dashboard supports hospitals' and health systems' current Antibiotic Stewardship programs, and allows users to toggle back and between DRG and prescribing physician information from antibiotic trending data; identifies IV-to-PO comparisons to benchmark; provides health system-level reporting; integrates antibiograms with antibiotic use trending; and serves as the foundation of antibiotic stewardship programs.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLH:GR €74.70 EUR +1.84

CLH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AmerisourceBergen Corp $94.73 USD +0.58
Celesio AG €26.50 EUR -0.17
Ecolab Inc $105.88 USD -0.49
Express Scripts Holding Co $84.80 USD -0.19
Walgreens Boots Alliance Inc $75.59 USD -0.43
View Industry Companies

Industry Analysis


Industry Average

Valuation CLH Industry Range
Price/Earnings 26.4x
Price/Sales 0.3x
Price/Book 4.5x
Price/Cash Flow 20.9x
TEV/Sales 0.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDINAL HEALTH INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at